Simultaneous determination of the inhibitory potency of herbal extracts on the activity of six major cytochrome P450 enzymes using liquid chromatography/mass spectrometry and automated online extraction
- 31 August 2004
- journal article
- research article
- Published by Wiley in Rapid Communications in Mass Spectrometry
- Vol. 18 (19) , 2273-2281
- https://doi.org/10.1002/rcm.1621
Abstract
Here we describe a liquid chromatography/mass spectrometry (LC/MS) method with automated online extraction (LC/LC/MS) to simultaneously determine the in vitro inhibitory potency of herbal extracts on six major human drug‐metabolising cytochrome P450 enzymes. Substrates were incubated with a commercially available mixture of CYP1A2/2C8/2C9/2C19/2D6 and 3A4 from baculovirus‐infected insect cells and the resulting metabolites were quantified with LC/LC/MS using electrospray ionisation in the selected ion monitoring mode. Consistent inhibitory activities were obtained for known inhibitors and plant extracts using the enzyme/substrate cocktail and the individual enzymes/substrates. Popular herbal remedies including devil's claw root (Harpagophytum procumbens), feverfew herb (Tanacetum parthenium), fo‐ti root (Polygonum multiflorum), kava‐kava root (Piper methysticum), peppermint oil (Mentha piperita), eucalyptus oil (Eucalyptus globulus), red clover blossom (Trifoliumpratense) and grapefruit juice (GJ; Citrus paradisi) could be identified as inhibitors of the applied CYP enzymes with IC50 values between 20 and 1000 μg/mL. Copyright © 2004 John Wiley & Sons, Ltd.Keywords
This publication has 30 references indexed in Scilit:
- Discovery of selective CYP11B2 (aldosterone synthase) inhibitors for the therapy of congestive heart failure and myocardial fibrosisEuropean Journal of Medicinal Chemistry, 2003
- High‐throughput cytochrome P450 inhibition assays by ultrafast gradient liquid chromatography with tandem mass spectrometry using monolithic columnsRapid Communications in Mass Spectrometry, 2003
- Liquid chromatography/tandem mass spectrometric determination of inhibition of human cytochrome P450 isozymes by resveratrol and resveratrol‐3‐sulfateRapid Communications in Mass Spectrometry, 2003
- High-throughput inhibition screening of major human cytochrome P450 enzymes using an in vitro cocktail and liquid chromatography–tandem mass spectrometryJournal of Pharmaceutical and Biomedical Analysis, 2003
- Inhibition of Cytochrome P450 3A4 by Extracts and Kavalactones ofPiper methysticum(Kava-Kava)Planta Medica, 2002
- Pharmacokinetics and Bioavailability of Quercetin Glycosides in HumansThe Journal of Clinical Pharmacology, 2001
- Drug–Grapefruit Juice InteractionsMayo Clinic Proceedings, 2000
- An in vitro evaluation of human cytochrome P450 3A4 inhibition by selected commercial herbal extracts and tincturesPhytomedicine, 2000
- Fully automated analysis of activities catalysed by the major human liver cytochrome P450 (CYP) enzymes: assessment of human CYP inhibition potentialXenobiotica, 1999
- Differential selectivity of cytochrome P450 inhibitors against probe substrates in human and rat liver microsomesBritish Journal of Clinical Pharmacology, 1998